Invictus MD

Category Archives : Investor Relations

Invictus MD announces $40,000,000 Bought Deal Private Placement of Convertible Debentures and notice of intention to exercise option on Acreage Pharms

On April 20, 2017, Posted by , In Investor Relations, With Comments Off on Invictus MD announces $40,000,000 Bought Deal Private Placement of Convertible Debentures and notice of intention to exercise option on Acreage Pharms

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC, April 20, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) announced today that it has engaged Canaccord Genuity Corp. and Eventus Capital Corp.,…

Canopy Growth Corporation Enters Into An Agreement with Invictus MD’s AB Laboratories For Cannabis Sales

On April 19, 2017, Posted by , In Investor Relations, With Comments Off on Canopy Growth Corporation Enters Into An Agreement with Invictus MD’s AB Laboratories For Cannabis Sales

VANCOUVER, BC, April 19, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that AB Laboratories Inc. (“AB Labs”), a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), will provide their unique products in…

Invictus MD’s Future Harvest Achieves Increase In Gross Margin Benefiting From Its Focus On The Burgeoning Global Cannabis Sector

On April 13, 2017, Posted by , In Investor Relations, With Comments Off on Invictus MD’s Future Harvest Achieves Increase In Gross Margin Benefiting From Its Focus On The Burgeoning Global Cannabis Sector

VANCOUVER, BC, April 13, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to report that Future Harvest Development Ltd. (“Future Harvest”), of which Invictus MD currently owns 82.5%, has generated $1.787 million in revenue for the 9 months ending…

Invictus MD’s Acreage Pharms Begins Cultivation with Commitment to Produce High Quality Cannabis

On April 11, 2017, Posted by , In Investor Relations, With Comments Off on Invictus MD’s Acreage Pharms Begins Cultivation with Commitment to Produce High Quality Cannabis

Vancouver, BC, April 11, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) announces that Acreage Pharms Ltd. (“Acreage Pharms”) which Invictus MD has the option to now acquire 100 percent and expect to exercise in short order, begins their new cultivation…

Invictus MD’s Chairman Provides March in Review

On April 5, 2017, Posted by , In Investor Relations, With Comments Off on Invictus MD’s Chairman Provides March in Review

VANCOUVER, BC, April 5, 2017 – INVICTUS MD STRATEGIES CORP. (TSXV:IMH) (“Invictus MD” or the “Company”), Canada’s Cannabis Company, is pleased to provide a month in review. March was a transformational time for Invictus MD as it worked to expand and solidify its cultivation portfolio with expansion plan forecasts of…